Foundations of Ibogaine
This course introduces clinicians, researchers, and students of psychedelic therapy to ibogaine, a powerful psychedelic with a complex history and unique therapeutic potential.
Course Overview
This course introduces clinicians, researchers, and students of psychedelic therapy to ibogaine, a powerful psychedelic with a complex history and unique therapeutic potential.
Who is this for?
Mental health professionals, researchers, clinicians, and curious learners.
Prerequisites
No psychotherapy license requirement is listed on the catalog card.
About the Provider
Fluence is a psychedelic therapy education company offering Professional Certificates and courses for psychedelic therapy, ketamine-assisted psychotherapy, psilocybin facilitation, harm reduction, and integration. Its current public catalog centers on Essentials of Psychedelic Therapy, Introduction to Psychedelic Therapy, and Professional Certificates in Psychedelic Harm Reduction and Integration Therapy, Ketamine-Assisted Psychotherapy, and Psilocybin Facilitation.
View Fluence profileCourse Details
- PricePrice on request
- FormatSelf-paced
- Lifecycle statusActive
- SkillsClinical practicePsychedelic research
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jun 1, 2026
Add Spravato® to Your Practice with Our 8-Phases Implementation Roadmap
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Advanced Training
By Therapsil
Focused short-form trainings in psychedelic safety, harm reduction, and clinical skill. One listed topic is Psychedelic First Aid, presented in collaboration with Neuma Centre.
Next cohort: May 20, 2026
Self-paced access